Scott G. Franzblau
Affiliations: | 2000- | Medicinal Chemistry and Pharmacognosy | University of Illinois at Chicago, Chicago, IL, United States |
Area:
PharmacyWebsite:
https://pharmacy.uic.edu/profiles/sgf/Google:
"Scott Gary Franzblau" OR "Scott G Franzblau"Bio:
https://mcp.uic.edu/people/franzblau_sg.html
Franzblau, Scott Gary. Isolation and characterization of coliforms : opportunistic pathogens and standard plate count bacteria from groundwater doctoral Dissertation University of Arizona (1982).
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Norval Arthur Sinclair | grad student | 1982 | University of Arizona (Microtree) | |
| (Isolation and characterization of coliforms : opportunistic pathogens and standard plate count bacteria from groundwater.) | ||||
Children
Sign in to add trainee| Taylor A. Choi | grad student | 2009 | University of Illinois, Chicago |
| Chang H. Hwang | grad student | 2012 | University of Illinois, Chicago |
| Hiten Gutka | grad student | 2013 | University of Illinois, Chicago |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nandikolla A, Khetmalis YM, Venkata Siva Kumar B, et al. (2023) Design, synthesis and biological evaluation of phenanthridine amide and 1,2,3-triazole analogues against . Rsc Medicinal Chemistry. 14: 1549-1561 |
| Khatri Chhetri B, Bhanushali R, Liang Y, et al. (2023) Isolation and Characterization of Anti-Mycobacterial Natural Products from a sp. Marine Sponge. Journal of Natural Products |
| Zhang J, Lair C, Roubert C, et al. (2023) Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents. Cell |
| Lee SY, Shetye GS, Son SR, et al. (2022) Anti-Microbial Activity of Aliphatic Alcohols from Chinese Black Cardamom (-) against H37Rv. Plants (Basel, Switzerland). 12 |
| Luo W, Huang Z, Xu D, et al. (2022) Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent. Bioorganic & Medicinal Chemistry Letters. 72: 128871 |
| Rajeswaran W, Ashkar SR, Lee PH, et al. (2022) Optimization of Benzoxazinorifamycins to Improve RNA Polymerase Inhibition and Treatment of Tuberculosis. Acs Infectious Diseases |
| Ashkar SR, Rajeswaran W, Lee PH, et al. (2022) Optimization of Benzoxazinorifamycins to Minimize hPXR Activation for the Treatment of Tuberculosis and HIV Coinfection. Acs Infectious Diseases |
| Huang Z, Luo W, Xu D, et al. (2022) Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent. Bioorganic & Medicinal Chemistry Letters. 71: 128824 |
| Sutherland HS, Lu GL, Tong AST, et al. (2021) Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis. European Journal of Medicinal Chemistry. 229: 114059 |
| Primi MC, Tavares MT, Klein LL, et al. (2021) Design of Novel Phosphopantetheine Adenylyltransferase Inhibitors: a Potential New Approach to Tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry |